<code id='D9CBA15171'></code><style id='D9CBA15171'></style>
    • <acronym id='D9CBA15171'></acronym>
      <center id='D9CBA15171'><center id='D9CBA15171'><tfoot id='D9CBA15171'></tfoot></center><abbr id='D9CBA15171'><dir id='D9CBA15171'><tfoot id='D9CBA15171'></tfoot><noframes id='D9CBA15171'>

    • <optgroup id='D9CBA15171'><strike id='D9CBA15171'><sup id='D9CBA15171'></sup></strike><code id='D9CBA15171'></code></optgroup>
        1. <b id='D9CBA15171'><label id='D9CBA15171'><select id='D9CBA15171'><dt id='D9CBA15171'><span id='D9CBA15171'></span></dt></select></label></b><u id='D9CBA15171'></u>
          <i id='D9CBA15171'><strike id='D9CBA15171'><tt id='D9CBA15171'><pre id='D9CBA15171'></pre></tt></strike></i>

          hotspot

          hotspot

          author:explore    Page View:24313
          HHS 2020
          PhRMA is suing the Biden administration over its new Medicare drug price negotiation program. Graeme Sloan/Sipa USA

          WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle to the courts.

          The pharmaceutical industry’s biggest lobbying group on Wednesday filed a long-expected lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for certain medicines.

          advertisement

          PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          comprehensive

          Tori Bowie and the unacceptable rates of Black maternal death
          Tori Bowie and the unacceptable rates of Black maternal death

          AlastairGrant/APThehorrorstoriesofBlackwomendyingorcomingclosetodeathinchildbirthneverseemtostopcomi

          read more
          AstraZeneca chief proposes a novel edit to the drug pricing bill
          AstraZeneca chief proposes a novel edit to the drug pricing bill

          PascalSoriotofAstraZenecaSTATAmongthepharmaceuticalcompanies’manyobjectionstotheBidenadministration’

          read more
          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more

          House GOP releases memo on Hunter Biden foreign business dealings, reviving old claims

          1:21HunterBidendepartstheJ.CalebBoggsFederalBuildingandUnitedStatesCourthouseonJuly26,2023inWilmingt